Tag: Prescription Drugs
Eflornithine + Sulindac Shows No Benefit in Adenomatous Polyposis
Incidence of disease progression not significantly lower with combo versus either drug alone
Intensive Therapy for HTN Tied to Drop in Orthostatic Hypotension
Meta-analysis of trials shows risk for OH reduced with intensive blood pressure treatment for hypertension
Darolutamide Boosts Survival in Nonmetastatic Prostate Cancer
Risk for death significantly lower versus placebo in nonmetastatic, castration-resistant prostate cancer
Baricitinib May Shorten Recovery Time in Hospitalized COVID-19 Patients
Adding anti-inflammatory drug to remdesivir seems to shorten time to hospital discharge
Shift Seen to Newer Agents to Treat Psoriasis
Biologics and small molecule inhibitors increasingly used for treatment of newly diagnosed psoriasis
Increase Seen in Hydroxychloroquine Rx by Nonroutine Specialists
New Rx increased 80-fold among specialists who do not typically prescribe these medications
Insurer, Insured Costs for HIV PrEP Rising in the United States
2014 to 2018 saw increase in estimated third-party, out-of-pocket payments per 30 TDF-FTC tablets
Early Therapy for Rheumatoid Arthritis May Slow Heart Disease
RA treatment response does not appear to impact improvement in vascular stiffness
Benefit of Adjuvant Dabrafenib + Trametinib Persists in Melanoma
Long-term benefit seen for relapse-free survival in stage III disease with BRAF V600E, V600K mutations
Anticholinergic Meds May Raise Risk for Cognitive Decline
Effects significantly worse among individuals with risk factors for Alzheimer disease
